Business Daily from THE HINDU group of publications
Saturday, Oct 27, 2007
ePaper | Mobile/PDA Version
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate Results - Pharmaceuticals
Vimta Labs Q2 net at Rs 1.6 cr

HYDERABAD: Vimta Lab’s net income nearly doubled to 1.61 crore (Rs 87 lakh) in the second quarter of current fiscal ended September 30.

The company clocked Rs 21.9 crore gross revenue (Rs 18.2 crore), according to a release. — Our Bureau

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Scale-up of business segments drives ITC Q2 net 13% higher

JK Cement Q2 net up 114%
L&T net jumps 73% buoyed by growth in sales
Cummins India PBT stays flat in Q2
Coromandel Fert Q2 net rises at Rs 66 cr
Room rates, occupancy prop Indian Hotels
GSK Pharma Q3 sales higher
Dabur Pharma net rises 23% but sales dip
Sun Pharma confident of closing Taro deal
Vimta Labs Q2 net at Rs 1.6 cr
Tata Steel posts 8% profit growth in Q2
Century Textiles Q2 net down
Apollo Tyres Q2 net zooms on stable raw material prices
Colgate Palmolive net more than doubles
i-flex net falls on higher expansion costs
Pioneer Investcorp net up
ICICI Pru posts 52% rise in new premium
ICI net rises 15%
Crisil net rises 70% at Rs 24 cr
Kotak Bank net doubles on higher interest, fee income in Q2
Federal Bank net up 37% on higher income
ING Vysa calls EGM to discuss pref issue
City Union net rises 64%
Rise in expenses weigh on Andhra Bank net
Syndicate Bank net up 11% on better yield on loans

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line